The perception of affective touch in Parkinson's disease and its relation to small fibre neuropathy by Kass-Iliyya, L et al.
Proposed journal section: Clinical and Translational Neuroscience 
Title: The perception of affective touch in Parkinson’s disease and its relation to 
small fibre neuropathy. 
Lewis Kass-Iliyya 1,2, Matthew Leung 2, Andrew Marshall 1,2,4, Paula Trotter 4, 
Christopher Kobylecki 1,2, Susannah Walker 4, David Gosal 1, Maria Jeziorska 3, Rayaz A. 
Malik 3, Francis McGlone 4, Monty A. Silverdale 1,2.  
1. Greater Manchester Neuroscience Centre, Department of Neurology, Salford 
Royal NHS Foundation Trust, Salford, UK. 
2. Division of Neuroscience and Experimental Psychology, University of 
Manchester, Manchester UK. 
3. Institute of Human Development, University of Manchester, Manchester, UK. 
4. School of Natural Science & Psychology, Liverpool John Moores University, 
Liverpool, UK. 
 
The address from which the work originated: Salford Royal NHS Foundation Trust, 
Stott Lane, Salford, M6 8HD 
Corresponding Author: Monty A. Silverdale, Neurology Department, Salford Royal 
NHS Foundation Trust, Stott Lane, Salford, M6 8HD. E-mail: 
monty.silverdale@srft.nhs.uk  Tel No: +44 (0)161 206 2574 
Running Title: Affective touch in Parkinson’s disease. 
Number of Pages: 21, Number of figures: 2, Number of Tables: 1. 
Number of Words in the Manuscript: 2610 
Number of Words in the Abstract: 233 
Keywords not appearing in the title: Hedonic, Pain, Cornea, Skin, C-tactile afferent. 
 
ABSTRACT 
Affective touch sensation is conducted by a sub-class of C-fibres in hairy skin known as 
C-Tactile (CT) afferents. CT afferents respond maximally to gentle skin stroking at 
velocities between 1-10 cm/sec. Parkinson’s disease (PD) is characterised by markedly 
reduced cutaneous C-fibres. It is not known if affective touch perception is influenced by 
C fibre density and if affective touch is impaired in PD compared to healthy controls. We 
predicted that perceived pleasantness to gentle stroking in PD would correlate with C 
afferent density and that affective touch perception would be impaired in PD compared to 
healthy controls. Twenty-four PD patients and 27 control subjects rated the pleasantness 
of brush stroking at an optimum CT stimulation velocity (3cm/sec) and two sub-optimal 
velocities (0.3cm/sec & 30cm/sec). PD patients underwent quantification of C-fibre 
density using skin biopsies and corneal confocal microscopy. All participants rated 
stroking velocity of 3cm/sec as the most pleasant with significantly lower ratings for 
0.3cm/sec and 30cm/sec. There was a significant positive correlation between C-fibre 
density and pleasantness ratings at 3cm/sec and 30cm/sec but not 0.3cm/sec. Mean 
pleasantness ratings were consistently higher in PD patients compared to control subjects 
across all three velocities. This study shows that perceived pleasantness to gentle touch 
correlate significantly with C-fibre density in PD. The higher perceived pleasantness in 
PD patients compared to controls suggests central sensitisation to peripheral inputs, which 





Cutaneous sensory modalities such as pain and touch are fundamental for normal 
interaction between organisms, their environment and one another. While the emotional 
aspect of pain has been acknowledged for a long time (Melzack & Casey, 1968) the 
affective dimension of touch has only been recognised in recent years (Morrison et al., 
2010). Vallbo (1999), using the technique of microneurography, identified and 
characterised a population of low threshold mechanosensory C- fibres, named C-Tactile 
afferents (CT). Unlike the more classically described C-fibres, CT afferents did not code 
for pain or itch, but responded optimally to low force/velocity gentle touch (Vallbo et al., 
1999).  CT afferents fire maximally when a gentle caressing or “stroking” is applied to the 
skin. In contrast to myelinated afferents that respond linearly to stimulus velocity, CT 
afferents respond optimally to a stroking velocity in the range of 1 – 10 cm/sec, which is 
also rated as the most pleasant. Stimulation velocities below and above this range (1-
10cm/sec) produce a sub-optimal CT response determined by lower firing frequency 
(Loken et al., 2009; Morrison et al., 2010). Furthermore, fMRI studies have demonstrated 
that stimulation of CT afferents activates areas in the brain that are associated with 
pleasure, including the insular cortex, as opposed to stimulation of myelinated fibres 
which activates the somatosensory areas of the cortex (Olausson et al., 2002; Rolls et al., 
2003). This emphasises the specialised role of CT afferents in mediating the affective 
component of the tactile experience. Recent evidence also suggests that there may be a 
relationship between low threshold CT afferents and pain pathways with CT afferents 
playing a pain-inhibiting role (Liljencrantz et al., 2013). 
 
The current view of CT afferents is that they provide the neurobiological basis for the 
formation and maintenance of social bonds and attachment relationships. They are 
proposed to be integral to an affiliative reward system that also involves several 
neuropeptides and neurotransmitters including serotonin, dopamine, opioids and oxytocin 
(Deakin, 1996; Berridge & Robinson, 1998; Le Merrer et al., 2009; Lee et al., 2009; 
Walker & McGlone, 2013). Moreover, impaired processing of affective touch has been 
associated with autistic spectrum disorders (McGlone et al., 2007; Cascio et al., 2012; 
Kaiser et al., 2016). Consequently, it is possible that pathological variations in peripheral 
nerve structures or central neurotransmitters may cause impaired processing of affective 
stimuli. 
 
Parkinson’s disease (PD) is a neurodegenerative condition characterised by both central 
monoamine depletion and reduced number of C-afferent fibres (Nolano et al., 2008; Kass-
Iliyya et al., 2015). Thus PD presents a good model for investigating the potential effects 
of central and peripheral neural impairment on affective touch processing. It is not known 
if affective touch perception is influenced by C-fibre density and if affective touch is 
impaired in PD compared to healthy controls. PD is also characterised by a range of non-
motor symptoms including pain, depression and apathy that may contribute to anhedonia 
(Aarsland et al., 2009; Defazio et al., 2013a).  
 
In this study, we assessed perceived pleasantness in response to skin stroking in a cohort 
of PD patients who had their C-fibre afferents quantified by two different methods: skin 
biopsy and corneal confocal microscopy.  We predicted that affective touch perception 
would correlate positively with C-fibre afferent density and that pleasantness would be 
reduced in Parkinson’s disease compared to age-matched healthy controls. We also 
sought to investigate the potential relationship between perceived pleasantness from CT 
afferent stimulation and other self-reported symptoms such depression, apathy and pain. 
 
MATERIALS AND METHODS 
Participants 
Twenty-four PD patients (age 51-78 years, mean age 63.7; 14 males) and 27 healthy 
volunteers (age 50-71 years, mean age 63.6; 11 males) took part in the study. PD patients 
were recruited from neurology clinics at Greater Manchester Neuroscience Centre. Nerve 
conduction studies were performed on all PD participants and none had significant large 
fibre or demyelinating neuropathy. Assessments were undertaken without withdrawing 
dopaminergic therapy (the “ON” state). Healthy controls were recruited via the Salford 
citizen scientist project (http://www.citizenscientist.org.uk). Control participants were 
selected to be free of all significant medical problems, including pain. The study was 
approved by NRES Committee London - Bromley (Ref No. 15/LO/0252). All participants 
provided their written informed consent. The conduct of the study adhered to the tenets of 
the declaration of Helsinki. 
 
Affective touch evaluation 
A goat-hair 70 mm wide artist brush was used to deliver strokes by a trained investigator. 
Experiments were undertaken in a quiet room on an examination couch. Strokes were 
delivered on each limb across a 10cm section of the skin. The lateral aspects of both 
forearms and shins were chosen to deliver brush strokes. One optimum velocity for CT 
afferents stimulation (3cm/sec) and two sub-optimal velocities (0.3cm/sec and 30cm/sec) 
were used to deliver brush strokes. For speed accuracy the investigator followed a moving 
bar across a10cm on a computer screen, which was not visible to the participant. The 
purpose-written programme was developed in LabVIEW (National Instrumetns, Texas, 
USA); project no. 2013-40, department of medical physics, Salford Royal NHS 
Foundation Trust. The programme randomised velocities of 0.3 cm/sec, 3 cm/sec and 30 
cm/sec. Each velocity was randomised three times producing a total of nine strokes per 
limb. The programme was designed so the same velocity is not randomised three times in 
a row to minimise CT afferent adaptation. There was a pause of 10 seconds between 
consecutive brush strokes to prevent CT afferents fatigue. Study participants rated 
pleasantness by placing a mark on a 100mm visual analogue scale (VAS) with the 
descriptor: “neutral/normal” at the lowest end and the descriptor: “very pleasant” at the 
highest end. The ratings were measured with a ruler and the mean of the three ratings for 
each velocity was calculated. The overall average rating for each velocity across all four 
limbs was used for the final analysis. 
 
Small fibre neuropathy 
Small nerve fibre quantification was only undertaken in the PD population. Twenty PD 
patients underwent skin biopsy and corneal confocal microscopy.  
 
Skin biopsies 
Two 3-mm punch skin biopsies were taken from the dorsa of both feet. The biopsies were 
immediately fixed in 4% paraformaldehyde, cryoprotected in graded solutions of sucrose, 
frozen and cut on a cryomicrotome (HM450, Microm International, Germany). Six 50 m 
sections per biopsy were immuno-stained using rabbit anti-human PGP 9.5 antibody 
(Abcam, Cambridge, U.K.) diluted 1/200, followed by biotinylated secondary antibody 
and Avidin D conjugated to horseradish peroxidase (both from Vector Laboratories, 
Peterborogh, UK). The nerve fibres were demonstrated using SG chromogen (Vector 
Laboratories, Peterborough, U.K.). A pathologist blinded to the participants’ clinical 
details performed tissue analysis. Intraepidermal nerve fibre density, i.e., the number of 
nerve fibres crossing basement membrane, was quantified according to established criteria 
and expressed as number per millimetre of epidermal length (Lauria et al., 2010). The 
mean between right and left intraepidermal nerve fibre density was calculated for each 
patient and used for analysis.  
 
Corneal Confocal Microscopy 
Corneal confocal microscopy is a non-invasive technique that allows in-vivo visualisation 
and quantification of corneal nerves. It is well established as a non-invasive surrogate 
method for studying small fibre neuropathy correlating significantly with skin biopsies 
(Quattrini et al., 2007; Chen et al., 2015). Corneal confocal microscopy was performed on 
both eyes using a Heidelberg Retina Tomograph III with a Rostock Cornea Module (HRT 
III RCM; Heidelberg Engineering GmbH, Heidelberg, Germany), as previously described 
(Tavakoli et al., 2013). Four to six high-resolution (1-2 m) images of the sub-basal 
plexus of each eye were obtained for all participants. A trained investigator who was 
blinded to participants’ details analysed corneal images separately. Corneal Nerve Fibre 
Density: The number of main nerves per square millimetre was quantified and the mean 
derived from the right and left eye. Corneal nerve fibre quantification was undertaken 
using semi-automated, purpose-written, proprietary software (CCMetrics; M.A. Dabbah, 
Imaging Science and Biomedical Engineering, Manchester, UK).  
 
Affective symptoms, apathy and pain 
Depression and anxiety: 
Affective symptoms were quantified using the Hospital Anxiety and Depression (HADS) 
Scale (Zigmond & Snaith, 1983). The HADS consists of 14 items, 7 of which relate to 
anxiety and the other 7 relate to depression. Each item is scored between 0-3. The overall 




All participants underwent assessment of apathy using the Lille Apathy Rating Scale 
(LARS) (Sockeel et al., 2006). The LARS consists of 33 items, divided into nine 
domains. The score ranges from -36 to +36, with higher score representing a greater 
degree of apathy. 
 
Pain intensity: 
Pain was only quantified in PD patients as healthy controls were selected to be pain-free. 
The Short Form McGill Pain Questionnaire (SFMPQ) (Melzack, 1987) was used for 
scoring pain intensity. SFMPQ consists of 15 descriptors (11 sensory; 4 affective), which 
are rated on an intensity scale from 0-3. SFMPQ also includes a present pain intensity 
index scored from 0-5 and a visual analogue scale (0-10), which are also included to 
provide an overall pain intensity score.  
 
Statistical Analysis 
IBM SPSS version 22 was used to analyse the data. All data are expressed as mean ± 
SEM. Normality of distribution was assessed using histograms and the Shapiro-Wilk test. 
A repeated measure ANOVA with between subject factor of group (PD vs Controls) and 
within subject factor of stroking velocity was used. For the purpose of ANOVA a 
departure from normality of pleasantness ratings at 0.3cm/sec was detected in control 
subjects therefore a square root transformation of all pleasantness ratings was undertaken 
to meet the assumption of normality. Individual means relating to demographics and other 
disease characteristics were compared using the student t test and where the data are not 
normally distributed the Mann-Whitney U test. Correlation between continuous variables 
was assessed using Pearson’s r coefficient. A p value of less than 0.05 was considered 
statistically significant. The p value was not corrected for multiple comparisons. 
 
RESULTS 
Participants’ characteristics are summarised in table 1. There was no significant difference 
in demographics between PD patients and control subjects.  
 
There was a significant positive correlation between perceived pleasantness at 3cm/sec 
and 30cm/sec and small fibre nerve density measured by both skin biopsies and corneal 
confocal microscopy in PD patients (p < 0.05) (Figure 1).  
Pain intensity in PD patients correlated positively with ratings of 0.3 cm/sec (Pearson’s r 
= 0.483, p = 0.02) but not with pleasantness ratings at other velocities. 
No significant relation was found between affective touch ratings and HADS or apathy 
scores in either PD or control subjects. Apathy and HADS scores were significantly 
higher in PD compared to controls (Table 1).  
 
For the ANOVA Mauchly’s test indicated that the assumption of sphericity had been 
violated, 2 (2) = 9.41, p = 0.009, therefore multivariate tests are reported ( = 0.85). 
Analysis of variance revealed a substantial main effect for velocity with all participants 
reporting increased pleasantness at 3cm/sec compared to 0.3cm/sec and 30cm/sec (Wilks’ 
Lambda = 0.26, F2,48 = 66.52,  p < 0.001, partial eta squared= 0.73). There was also a 
main effect of group with PD patients rating brush strokes as more pleasant across all 
three velocities (F1,49 = 5,  p = 0.030, partial eta squared = 0.093) but this was most 
notable at 0.3cm/sec (Figure 2 & Table 1).   
 
DISCUSSION 
We have found a linear relationship between C-fibres density in PD patients and 
perceived pleasantness of gentle brush stroking at 3cm/sec and 30cm/sec however, such 
relationship was not present with very slow brush strokes (0.3cm/sec) which was also 
reported as the least pleasant (Figure 2). Pleasantness rating was highest with stroking 
velocity of 3cm/sec in both PD patients and healthy volunteers. Similar to previous 
studies, reported pleasantness was higher at 30cm/sec compared to 0.3cm/sec. (Loken et 
al., 2009; Macefield et al., 2014) despite both velocities being suboptimal for CT 
stimulation demonstrated by low firing rate on microneurography (Loken et al., 2009).   
 
We have measured small nerve fibre density in two locations: the hairy skin of the dorsa 
of both feet and both corneas.  Skin denervation in PD is likely to involve CT afferents 
although corneal denervation is not expected to include CT afferents given their specialist 
role in affective touch. Nevertheless, corneal confocal microscopy has been shown to 
provide a surrogate measure of cutaneous C fibres density (Quattrini et al., 2007; Kass-
Iliyya et al., 2015).  Therefore the correlation of perceived pleasantness with corneal 
nerve density is likely to reflect an indirect association. 
 
Although these findings suggest a relationship between small nerve fibre density and 
perceived pleasantness it is difficult to draw firm conclusions with regards to the role of 
CT fibres due to correlations being present in a suboptimal stimulation velocity 
(30cm/sec) and the difficulty in stimulating CT afferents in isolation without stimulating 
other low threshold mechanoreceptors. 
 
Contrary to our hypothesis, PD patients compared to controls reported higher pleasantness 
to brush stroking across all velocities despite having significantly reduced C afferents. 
This was particularly noted at the slow speed (0.3cm/sec), which is the least effective for 
inducing pleasantness. Interestingly this abnormally high rating of 0.3cm/sec also 
correlated with pain intensity in PD, suggesting a potentially common pathophysiology 
relating to abnormal central sensitisation to reward and pain. This is plausible given the 
significant overlap between brain regions responsible for processing pain and reward 
(mesolimbic dopamine pathway, prefrontal medial cortex, insular cortex) as well as the 
common neurochemistry between the two systems (opioid & dopamine) (Schultz, 2007; 
Smith & Berridge, 2007; Wager et al., 2007; Leknes & Tracey, 2008). Several studies 
have provided evidence of upregulation of central processing of nociceptive input, which 
is postulated to account for the increased prevalence of pain in PD (Defazio et al., 2013b). 
It is unknown if this also extends to processing of affective touch however this is 
suggested by the findings of our study. 
 
Another potential explanation for the higher pleasantness rating in our PD patients is that 
they did not withdraw dopamine therapy during the experiment. Studies have shown that 
PD patients with impulse control disorders have higher release of dopamine in the ventral 
striatum during reward related tasks compared to patients who do not exhibit such 
behaviour (Steeves et al., 2009; O'Sullivan et al., 2011; Wu et al., 2015). Dopamine has 
also been reported to modulate tactile temporal perception (Nelson et al., 2012). It is 
possible therefore that dopamine treatment might have influenced the perception of 
affective touch in our PD cohort. Curiously this poses the question of the potential role of 
dopamine in coding for affective touch perception.  
 
Although our PD patients had significantly higher scores of apathy and depression 
compared to controls we did not find a relationship with affective touch ratings at any of 
the three velocities. This suggests that variations in affective touch perception may not be 
an important cause for apathy or mood change and other factors related to PD are more 
important. However our study confirms higher rates of depression, anxiety and apathy in 
PD compared to controls, which is widely reported in the literature (Aarsland et al., 2009; 
Dujardin et al., 2014). This may be secondary to the disease itself or could result from 
monoamine depletion involving serotonin and noradrenaline as well as dopamine. 
 
CT afferents are an intriguing sub-group of cutaneous small nerve fibres that have only 
come to light in the last decade. Their function in disease states has not been explored. In 
this study we have demonstrated a relationship between small nerve fibre density and 
perceived pleasantness and have documented varying pleasantness across different 
stroking velocities in a group of patients with Parkinson’s disease. Nevertheless, 
stimulating CT afferents in isolation was not possible without microneurography 
techniques, which were not available in this study, and we accept this as a limitation. The 
other limitation is performing the experiment in the “ON” state only. Assessing the 
affective touch perception in both the “ON” and the practically defined “OFF” states 
(after withdrawing dopamine) would have been needed to ascertain whether dopaminergic 
therapy influenced the perceived pleasantness of brush stroking. This question should be 
addressed in future studies and is of particular relevance given the role of the CT afferents 
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 Table 1. Demographics and clinical characteristics of Parkinson’s disease (PD) patients and healthy controls. Perceived pleasantness to 
brush stroking marked on a 1-100 visual analogue scale is also provided. Data are presented as Means ± SEM (range). SFMPQ: Short 
Form McGill Pain Questionnaire. HADS: Hospital and Anxiety Scale. LARS: Lille Apathy Rating Scale. Means were compared using 
the student t test in all parameters except for pleasantness rating at 0.3cm/sec where the non-parametric Mann Whitney U test was used.
 PD patients (n = 24) Controls (n = 27)  p value 
Gender 14 males, 10 females 11 males, 16 females 0.210 
Age  (years) 63.7 ± 1.6 (51 – 78) 63.6 ± 1.1 (50 – 71) 0.938 
Disease duration (years) 7.7 ± 0.9 years (1.2 – 18) -  
Hoehn and Yahr Stage.  I = 8, II = 12, III = 4 -  
SFMPQ 23 ± 2.6 (0 – 51) -  
HADS 18.9 ± 1.9 (2 – 34) 8.8 ± 1.1 (0 – 20) <0.001 
LARS -20.4 ± 1.1 (-32 – -9) -24 ± 0.8 (-32 – -13)   0.003 
Pleasantness at 0.3cm/sec 30.3 ± 4.3 (5 – 77) 16.8 ± 2.8 (0 – 58)   0.017 
Pleasantness at 3cm/sec 60.3 ± 4.2 (19 – 92) 55.0 ± 4.0 (19 – 92)   0.371 
Pleasantness at 30cm/sec 48.3 ± 3.8 (19 – 87) 41.2 ± 4.6 (1 – 96)   0.247 
Figure legends 
 
Figure 1 Correlation between pleasantness ratings at 3cm/sec and 30cm/sec and small 
fibre nerve density measured by skin biopsies (A & B) and corneal confocal microscopy 
(C & D). Pleasantness rating was measured with a 100mm visual analogue scale (VAS). 
Correlation coefficient (Pearson’s r) and significance are also shown. 
 
 Figure 2 Mean and SEM of affective touch ratings in Parkinson’s disease (PD) and 
Controls using three different velocities of brush strokes. Pleasantness is rated using a 0-
100 visual analogue scale (VAS) and square rooted to meet the assumption of normality. 
 
 
 
 
 
